Found 9 matching trials
DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization
PHASE2This is a prospective, randomized, double-blind, double-dummy, and controll...
Location
Central Army Hospital RSPAD Gatot Soebroto
Safety and Efficacy of DLBS1033 in Healthy Subjects
NAThe objective of this study are:
1. To evaluate the safety of DLBS1033 in ...
Location
PT Equilab International
DLBS1033 for the Treatment of Acute Ischemic Stroke
PHASE3This is a prospective, randomized, double-blind, and controlled clinical st...
Location
RSUD R. Syamsudin, SH
DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease
PHASE2This is a prospective, randomized, double-blind, double-dummy, and controll...
Location
Department of Internal Medicine, Faculty of Medicine, University of Udayana/Sanglah Hospital
Oral DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke: Impact on Inflammatory Biomarkers and Outcomes
PHASE4This randomized, double-blind, placebo-controlled trial aims to evaluate th...
Location
Dr. Moewardi Regional General Hospital
The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers
PHASE2DLBS1033 is bioactive protein fraction which extracted from Lumbricus rubel...
Location
Indonesia University
Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus
PHASE4This is a prospective, double-blind, randomized, and controlled study. The ...
Location
Department of Internal Medicine, Faculty of Medicine, University of Andalas/ dr. M. Djamil Padang Hospital
Effect of DLBS1033 After Primary PCI in Patients With STE-ACS
PHASE2This is a prospective, randomized, double-blind, double-dummy, and controll...
Location
Binawaluya Cardiac Hospital
DLBS1033 for Acute Ischemic Stroke Patients
PHASE2This is a prospective, randomized, double-blind, and controlled clinical st...
Location
Neurology Department, Dr. Kariadi General Hospital